Johnson & Johnson Q2 FY2025 Earnings Call

Johnson & Johnson (JNJ)

Earnings Call FY2025 Q2 Call date: 2024-10-15 Concluded

Quarter scorecard

Revenue

$23.74B

+10.3% YoY

Diluted EPS

$2.29

+16.8% YoY

Gross margin

67.9%

-2.1 pp YoY

Net income

$5.54B

+7.6% YoY

Innovative Medicine $15.20B

+10.7%

MedTech $8.54B

+9.7%

Dividend / share

$1.24

ex Nov 26